Drug Companies

Congressional lawmakers have renewed efforts to give the Food and Drug Administration more power to deny drug applications for opioids that are not proven clinically superior to and lower risk than currently...

The Democrats’ deal also would limit insulin costs and cap annual out-of-pocket spending at $2,000 for seniors. Pharmacy benefit managers would face transparency requirements as well.

Trial participants reported significant near-vision improvements under low-light conditions — without losing distance vision, reports Allergan, which is seeking FDA approval for the drug.

An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.

Moderna’s trial vaccine will have big distribution advantages over Pfizer’s similarly successful candidate if both drugs are approved by the FDA.

Documents released on Wednesday show that the agency’s staff members already are enthusiastic about the drug’s prospects. If approved, aducanumab could be the first drug on the market to slow Alzheimer’s...

The antiviral remdesivir is priced “well below” the projected value of most patient treatments, the drugmaker says. Others claim the cost is too high, considering that its development was partly taxpayer...

Drug class provides cardiovascular protection for all with type 2 diabetes … Timing of first flu virus exposure sets immunity for life … Resetting our internal clocks might help control diabetes …...

Surprise move: Biogen presses ahead on failed Alzheimer’s drug … Robot ‘colleague’ in pilot test for dementia patients at two nursing homes … Breaking thought patterns raises chance of depression...

A large pharmaceutical company has come under fire, following reports that it failed to pursue a promising Alzheimer’s disease treatment.